Trial intelligence / Profile preview

Analgesia After Total Knee Arthroplasty

NCT00869037Phase 4Unknown

Sponsor
University of Manitoba
Start
Mar 2009
Primary completion
Jul 2011
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in pain, sponsored by University of Manitoba. Status: unknown.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

pain

Beyond the preview

Go deeper on NCT00869037.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00869037.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call